Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


26.11.2018

2 Ann Surg Oncol
1 Biochem Biophys Res Commun
2 Br J Dermatol
1 Cancer Lett
1 Int J Cancer
4 J Am Acad Dermatol
1 J Invest Dermatol
3 Melanoma Res
1 Ophthalmology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. KROON HM, Thompson JF
    Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?
    Ann Surg Oncol. 2018 Nov 21. pii: 10.1245/s10434-018-7067.
    PubMed     Text format    

  2. BERTOLLI E, Franke V, Calsavara VF, de Macedo MP, et al
    Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7038.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. IWAKAMI Y, Yokoyama S, Watanabe K, Hayakawa Y, et al
    STAM-binding protein regulates melanoma metastasis through SLUG stabilization.
    Biochem Biophys Res Commun. 2018 Nov 16. pii: S0006-291X(18)32483.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. POTRONY M, Puig-Butille JA, Ribera-Sola M, Iyer V, et al
    POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Br J Dermatol. 2018 Nov 19. doi: 10.1111/bjd.17443.
    PubMed     Text format     Abstract available

  5. MAEDA T, Yoshino K, Nagai K, Oaku S, et al
    Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients.
    Br J Dermatol. 2018 Nov 17. doi: 10.1111/bjd.17434.
    PubMed     Text format     Abstract available


    Cancer Lett

  6. FURST K, Steder M, Logotheti S, Angerilli A, et al
    DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
    Cancer Lett. 2018;442:299-309.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. RUEEGG CS, Stenehjem JS, Egger M, Ghiasvand R, et al
    Challenges in Assessing the Sunscreen-Melanoma Association.
    Int J Cancer. 2018 Nov 16. doi: 10.1002/ijc.31997.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  8. LAKE E
    Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
    J Am Acad Dermatol. 2018 Oct 31. pii: S0190-9622(18)32819.
    PubMed     Text format     Abstract available

  9. RZEPECKI AK, Hwang CD, Etzkorn JR, Shin TM, et al
    The "Rule of 10s" versus the "Rule of 2s": High complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas.
    J Am Acad Dermatol. 2018 Nov 14. pii: S0190-9622(18)32892.
    PubMed     Text format     Abstract available

  10. RIBERO S, Galli F, Osella-Abate S, Bertero L, et al
    Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
    J Am Acad Dermatol. 2018 Nov 14. pii: S0190-9622(18)32212.
    PubMed     Text format     Abstract available

  11. FIX W, Etzkorn JR, Shin TM, Howe N, et al
    Melanomas of the head and neck have high local recurrence risk features and require tissue rearranging reconstruction more commonly than BCC and SCC: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
    J Am Acad Dermatol. 2018 Nov 17. pii: S0190-9622(18)32910.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  12. ATKINSON A, Renziehausen A, Wang H, Lo Nigro C, et al
    The collagen prolyl hydroxylases are bifunctional growth regulators in melanoma.
    J Invest Dermatol. 2018 Nov 16. pii: S0022-202X(18)32822.
    PubMed     Text format     Abstract available


    Melanoma Res

  13. WU K, Wang W, Ye Y, Huang J, et al
    Integration of protein interaction and gene co-expression information for identification of melanoma candidate genes.
    Melanoma Res. 2018 Nov 19. doi: 10.1097/CMR.0000000000000525.
    PubMed     Text format     Abstract available

  14. ROMANO S, D'Arrigo P, Tufano M, Staibano S, et al
    TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-alpha inhibition.
    Melanoma Res. 2018 Nov 19. doi: 10.1097/CMR.0000000000000553.
    PubMed     Text format     Abstract available

  15. URBONAS V, Smailyte G, Urbonaite GV, Dulskas A, et al
    Natural killer cell-based immunotherapy: a new fighter against melanoma?
    Melanoma Res. 2018 Nov 19. doi: 10.1097/CMR.0000000000000552.
    PubMed     Text format     Abstract available


    Ophthalmology

  16. PAPUDESU C, Reddy SG, Potter HD
    Ocular Metastasis of Cutaneous BRAF Wild-Type Melanoma.
    Ophthalmology. 2018;125:1966.
    PubMed     Text format    


    PLoS One

  17. OHMI Y, Kambe M, Ohkawa Y, Hamamura K, et al
    Differential roles of gangliosides in malignant properties of melanomas.
    PLoS One. 2018;13:e0206881.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: